YOLFTbeta
Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN · NASDAQ · Healthcare / Biotechnology

2.99USD+0.22 (+7.94%)

Price History

Full chart

Market Stats

Previous Close2.77
Open2.91
Day Range2.80 – 2.99
52-Week Range3.29 – 141.50
Volume13.47K
Market Cap5.74M
P/E (TTM)0.00
Forward P/E0.00
EPS-24.03
Dividend Yield0.00%
Beta0.71
50-Day Avg4.81
200-Day Avg15.21

About

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Chris Kim J.D., L.L.M.
  • Employees1
  • Headquarters12611 Hiddencreek Way, Cerritos, CA, United States, 90703, USA
  • Websitehttps://liminatuspharma.com

Leadership

  • Mr. Chris Kim J.D., L.L.M.CEO, Chairman & President · b. 1960
  • Mr. Scott DamChief Financial Officer · b. 1979
  • Dr. Beom Kyu ChoiChief Technology Officer & Member of Scientific Advisory Board · b. 1972
  • Dr. Byong Chul Yoo Ph.D.Chief Science Officer & Member of Scientific Advisory Board · b. 1973

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-0000
Operating Income-2.53M-2.71M-2.59M-2.91M-2.97M
EBITDA4.37M-2.71M-1.09M-2.75M-9.99M
Net Income4.37M-2.93M-1.23M-2.90M-10.21M
R&D3.80M1.85M3.76M2.69M0
Interest Expense-219.00K175.00K138.10K215.90K

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets276.44M15.49M4.50M2.83M512.79K
Total Liabilities21.57M14.19M15.19M18.70M10.33M
Total Equity254.87M1.29M-10.69M-15.87M-9.81M
Cash336.23K5.05M434.00K804.54K337.65K
Total Debt90.00K16.50M16.05M5.12M1.44M
Net Debt-246.23K11.45M15.62M4.32M1.10M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.22M-869.00K-3.35M-3.11M-9.96M
Investing Cash Flow-276.00M263.96M-819.00K1.97M-788.11K
Financing Cash Flow277.55M5.92M-450.00K1.05M11.03M
Capital Expenditure000013.11K
Free Cash Flow-1.22M-869.00K-3.35M-3.11M-9.98M
FCF to OCF100.00%100.00%100.00%100.00%100.13%

Earnings

Report DateJul 22, 2021Nov 22, 2021Dec 31, 2021Apr 18, 2022Aug 19, 2022Nov 21, 2022Dec 31, 2022Apr 18, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Apr 16, 2025Jun 30, 2025Oct 6, 2025Dec 31, 2025Mar 31, 2026Aug 14, 2026Nov 12, 2026
EPS Estimate-----------------0.00----
EPS Actual-0.060.20-0.39-0.010.110.08-0.06-0.081.40-1.99-3.33-5.90-3.72-4.48-6.14-0.120.24-0.07-15.09-1.56-0.03-
Surprise----------------------
Timing----------------------

Key Statistics & Ratios

Market Cap5.74M
Enterprise Value3.84M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book18.01
EPS-24.03
Book Value0.269
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-4.06M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-95.65%
Shares Outstanding1.34M
Shares Float919.25K
Beta0.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
1.41%
Insiders
33.75%
Retail / Other
64.84%

Top Institutional Holders

  • Cygnus Capital Advisors, LLC
    350.00K0.52%
  • Geode Capital Management, LLC
    117.78K0.18%
  • Jane Street Group LLC
    71.32K0.11%
  • Citadel Advisors Llc
    56.09K0.08%
  • UBS Group AG
    54.58K0.08%
  • Vanguard Capital Management, LLC
    50.44K0.08%
  • Virtu Financial LLC
    27.47K0.04%
  • Vanguard Fiduciary Trust Co
    22.98K0.03%
  • TWO SIGMA SECURITIES, LLC
    22.04K0.03%
  • State Street Corp
    19.00K0.03%
  • BlackRock Inc
    13.25K0.02%
  • JustInvest LLC
    13.15K0.02%
  • Tower Research Capital LLC
    7.57K0.01%
  • Citigroup Inc
    6.77K0.01%
  • Two Sigma Investments LLC
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    120.45K0.18%
  • Fidelity Total Market Index
    8.10K0.01%
  • Fidelity Series Total Market Index
    6.20K0.01%

Stock Splits

  • Aug 21, 20261:50